Pure Global
NCT05629000

Optimization Strategy of Carotid Artery Stenosis

Cohort of Optimized Assessment Strategy of Carotid Artery Stenosis
Peking Union Medical College Hospital·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Carotid Artery Stenosis
Drug/Device/Intervention
Carotid revascularization
Study type
Observational
Intervention type
procedure
Sponsor & location
Primary sponsor
Peking Union Medical College Hospital
Location
Beijing, China
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2015
End date
Dec 31, 2026
Enrollment
1000 participants
Primary outcome

stroke,cardiac infarction,transient ischemic attack,cerebral hyperperfusion syndrome,death

Summary

The goal of this observational study is to learn about how to utilize multiple evaluation
 techniques in carotid artery stenosis patients for optimizing assessment of diagnosis and
 treatment strategy.
 
 The main questions it aims to answer are:
 
 - Identify best strategy that use multi-modal MRI and CT to assess patients' cerebral
 lesions and perfusion.
 
 - Identify best strategy that use multi-modal MRI, PET-MRI ultrasound and CT to assess
 components and characters of patients' carotid plaques.
 
 Participants will accept imaging examination before and after surgery. And doctors will
 collect basic characteristics, imaging results and biological samples of patients for
 analysis.

ICD-10 classifications
Occlusion and stenosis of carotid arteryCarotid artery syndrome (hemispheric)Injury of carotid arteryAneurysm and dissection of carotid arteryOcclusion and stenosis of vertebral artery
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05629000
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05629000 through Pure Global AI's free database. This phase not specified trial is sponsored by Peking Union Medical College Hospital and is currently Recruiting. The study focuses on Carotid Artery Stenosis. Target enrollment is 1000 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.